Patent Assignment
Reel/Frame 027377/0025
Change of Name
Recorded: 2011-12-13
Pages: 4
Assignor
BERTEK PHARMACEUTICALS INC.
Executed: 2004-06-21
Assignee
MYLAN BERTEK PHARMACEUTICALS INC.
12720 DAIRY ASHFORD, SUGARLAND, TEXAS, 77478
Covered Property
(1)
Use of Vitamin D Analogs to Treat Conditions Related to Increased Oxidative Stress
Patent:
6,262,041 →
Application:
09/287,544 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Release of Security Interest
Nov 18, 2011
From: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: MYLAN TECHNOLOGIES, INC.; DEY, INC. (F/K/A DEY LABORATORIES, INC.); MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN PHARMACEUTICALS, INC.
Reel/Frame 027261/0928 →
Security Agreement
Nov 21, 2011
From: MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.; MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.)
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027270/0799 →
Patent Release
Dec 10, 2012
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: DEY PHARMA L.P. (F/K/A DEY, L.P.); MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.
Reel/Frame 029440/0967 →